- Home
- LTC vs ARQT Comparison
LTC vs ARQT Comparison
Compare LTC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- ARQT
- Stock Information
- Founded
- LTC 1992
- ARQT 2016
- Country
- LTC United States
- ARQT United States
- Employees
- LTC N/A
- ARQT N/A
- Industry
- LTC Real Estate Investment Trusts
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- LTC Real Estate
- ARQT Health Care
- Exchange
- LTC Nasdaq
- ARQT Nasdaq
- Market Cap
- LTC 1.6B
- ARQT 1.7B
- IPO Year
- LTC 1992
- ARQT 2020
- Fundamental
- Price
- LTC $35.28
- ARQT $15.00
- Analyst Decision
- LTC Hold
- ARQT Strong Buy
- Analyst Count
- LTC 5
- ARQT 6
- Target Price
- LTC $37.80
- ARQT $18.80
- AVG Volume (30 Days)
- LTC 355.4K
- ARQT 1.9M
- Earning Date
- LTC 07-28-2025
- ARQT 08-13-2025
- Dividend Yield
- LTC 6.52%
- ARQT N/A
- EPS Growth
- LTC 0.36
- ARQT N/A
- EPS
- LTC 1.93
- ARQT N/A
- Revenue
- LTC $202,686,000.00
- ARQT $212,819,000.00
- Revenue This Year
- LTC N/A
- ARQT $61.01
- Revenue Next Year
- LTC $11.33
- ARQT $37.95
- P/E Ratio
- LTC $18.29
- ARQT N/A
- Revenue Growth
- LTC 3.98
- ARQT 100.03
- 52 Week Low
- LTC $31.70
- ARQT $7.86
- 52 Week High
- LTC $39.89
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- LTC 51.84
- ARQT 60.23
- Support Level
- LTC $34.90
- ARQT $13.06
- Resistance Level
- LTC $35.81
- ARQT $15.36
- Average True Range (ATR)
- LTC 0.55
- ARQT 0.66
- MACD
- LTC 0.05
- ARQT 0.12
- Stochastic Oscillator
- LTC 66.83
- ARQT 82.57
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.